160 related articles for article (PubMed ID: 10853669)
1. Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitors.
Zhao Z; Arnaiz DO; Griedel B; Sakata S; Dallas JL; Whitlow M; Trinh L; Post J; Liang A; Morrissey MM; Shaw KJ
Bioorg Med Chem Lett; 2000 May; 10(9):963-6. PubMed ID: 10853669
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors.
Arnaiz DO; Zhao Z; Liang A; Trinh L; Witlow M; Koovakkat SK; Shaw KJ
Bioorg Med Chem Lett; 2000 May; 10(9):957-61. PubMed ID: 10853668
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
Buckman BO; Mohan R; Koovakkat S; Liang A; Trinh L; Morrissey MM
Bioorg Med Chem Lett; 1998 Aug; 8(16):2235-40. PubMed ID: 9873520
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor.
Nishida H; Miyazaki Y; Kitamura Y; Ohashi M; Matsusue T; Okamoto A; Hosaka Y; Ohnishi S; Mochizuki H
Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1237-44. PubMed ID: 11605647
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
Chou YL; Davey DD; Eagen KA; Griedel BD; Karanjawala R; Phillips GB; Sacchi KL; Shaw KJ; Wu SC; Lentz D; Liang AM; Trinh L; Morrissey MM; Kochanny MJ
Bioorg Med Chem Lett; 2003 Feb; 13(3):507-11. PubMed ID: 12565961
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological activity of YM-60828 derivatives. Part 2: potent and orally-bioavailable factor Xa inhibitors based on benzothiadiazine-4-one template.
Hirayama F; Koshio H; Katayama N; Ishihara T; Kaizawa H; Taniuchi Y; Sato K; Sakai-Moritani Y; Kaku S; Kurihara H; Kawasaki T; Matsumoto Y; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2003 Feb; 11(3):367-81. PubMed ID: 12517432
[TBL] [Abstract][Full Text] [Related]
7. Benzimidazole-based fXa inhibitors with improved thrombin and trypsin selectivity.
Shaw KJ; Guilford WJ; Griedel BD; Sakata S; Trinh L; Wu S; Xu W; Zhao Z; Morrissey MM
Bioorg Med Chem Lett; 2002 May; 12(9):1311-4. PubMed ID: 11965378
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity.
Wiley MR; Weir LC; Briggs S; Bryan NA; Buben J; Campbell C; Chirgadze NY; Conrad RC; Craft TJ; Ficorilli JV; Franciskovich JB; Froelich LL; Gifford-Moore DS; Goodson T; Herron DK; Klimkowski VJ; Kurz KD; Kyle JA; Masters JJ; Ratz AM; Milot G; Shuman RT; Smith T; Smith GF; Tebbe AL; Tinsley JM
J Med Chem; 2000 Mar; 43(5):883-99. PubMed ID: 10715155
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and structure-activity relationships of benzoxazinone-based factor Xa inhibitors.
Huang W; Zhang P; Zuckett JF; Wang L; Woolfrey J; Song Y; Jia ZJ; Clizbe LA; Su T; Tran K; Huang B; Wong P; Sinha U; Park G; Reed A; Malinowski J; Hollenbach SJ; Scarborough RM; Zhu BY
Bioorg Med Chem Lett; 2003 Feb; 13(3):561-6. PubMed ID: 12565972
[TBL] [Abstract][Full Text] [Related]
10. 1,2-Disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors.
Takeuchi K; Bastian JA; Gifford-Moore DS; Harper RW; Miller SC; Mullaney JT; Sall DJ; Smith GF; Zhang M; Fisher MJ
Bioorg Med Chem Lett; 2000 Oct; 10(20):2347-51. PubMed ID: 11055353
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 2.
Quan ML; Ellis CD; Liauw AY; Alexander RS; Knabb RM; Lam G; Wright MR; Wong PC; Wexler RR
J Med Chem; 1999 Jul; 42(15):2760-73. PubMed ID: 10425087
[TBL] [Abstract][Full Text] [Related]
12. Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.
Wang W; Yuan J; Fu X; Meng F; Zhang S; Xu W; Xu Y; Huang C
Molecules; 2016 Apr; 21(4):491. PubMed ID: 27089317
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of potent and selective amidino bicyclic factor Xa inhibitors.
Han Q; Dominguez C; Stouten PF; Park JM; Duffy DE; Galemmo RA; Rossi KA; Alexander RS; Smallwood AM; Wong PC; Wright MM; Luettgen JM; Knabb RM; Wexler RR
J Med Chem; 2000 Nov; 43(23):4398-415. PubMed ID: 11087565
[TBL] [Abstract][Full Text] [Related]
14. Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agents.
Ries UJ; Priepke HW; Hauel NH; Handschuh S; Mihm G; Stassen JM; Wienen W; Nar H
Bioorg Med Chem Lett; 2003 Jul; 13(14):2297-302. PubMed ID: 12824021
[TBL] [Abstract][Full Text] [Related]
15. Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa.
Mederski WW; Dorsch D; Anzali S; Gleitz J; Cezanne B; Tsaklakidis C
Bioorg Med Chem Lett; 2004 Jul; 14(14):3763-9. PubMed ID: 15203158
[TBL] [Abstract][Full Text] [Related]
16. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
17. Discovery of the factor Xa inhibitor, ZK 807834 (CI-1031).
Light DR; Guilford WJ
Curr Top Med Chem; 2001 Jun; 1(2):121-36. PubMed ID: 11899248
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and activity of 2,6-diphenoxypyridine-derived factor Xa inhibitors.
Phillips G; Davey DD; Eagen KA; Koovakkat SK; Liang A; Ng HP; Pinkerton M; Trinh L; Whitlow M; Beatty AM; Morrissey MM
J Med Chem; 1999 May; 42(10):1749-56. PubMed ID: 10346927
[TBL] [Abstract][Full Text] [Related]
19. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors IV. A series of new derivatives containing a spiro[5H-oxazolo[3,2-a]pyrazine-2(3H),4'-piperidin]-5-one skeleton.
Nishida H; Mukaihira T; Saitoh F; Harada K; Fukui M; Matsusue T; Okamoto A; Hosaka Y; Matsumoto M; Shiromizu I; Ohnishi S; Mochizuki H
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):406-12. PubMed ID: 15056953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
